Nervous System disease research hub

A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE ASCENDING, SINGLE-DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF RAY121 IN HEALTHY VOLUNTEERS

This early-stage study is looking at a new medicine called RAY121 for nerve conditions. We want to see if it's safe and how it works in healthy people, checking for any side effects and how the body handles the medicine.